Abstract:Objective To evaluate the prognostic factors of invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas.Methods The retrospective case-control study was adopted.The clinical data of 110 patients who were confirmed as with IPMN of the pancreas by pathological examination at the Zhongshan Hospital of Fudan University from June 2005 to April 2014 were collected.Forty-one patients with invasive IPMN were screened for eligibility.Patients underwent chemotherapy according to the chemotherapy regimens of pancreatic ductal adenocarcinoma.The follow-up using outpatient examination and telephone interview was performed to detect the survival of patients by tumor markers,B-ultrasound and computed tomography (CT) once every half year up to February 2016.Analysis indicators included (1) follow-up situation:1-,3-,5-year survival rates,(2) prognostic factors:gender,age,tumor location,surgical procedures,tumor diameter,T stage,nerve invasion,lymph node invasion,heteromorphic resection margin,histopathological subtypes,pathological type of canceration,(3) stratified analysis:independent prognostic factors.The survival curve was drawn by the KaplanMeier method.Survival rate was calculated and univariate analysis was analyzed by the chi-square test.The multivariate analysis was done using the COX regression model,and survival analysis was done by the Log-rank test.Results (1) Follow-up:41 patients with invasive IPMN of the pancreas were followed up for 4.3-125.8months with a median follow-up time of 26.4 months,and median survival time and 1-,3-,5-year survival rates were respectively 32.8 months,90％,45％ and 39％.(2) Analysis of prognostic factors:the results of univariate analysis showed that nerve invasion and lymph node invasion were related factors affecting the prognosis of patients with invasive IPMN of the pancreas (x2 =5.996,11.552,P ＜ 0.05).The results of multivariate analysis showed that lymph node invasion was an independent risk factor affecting the poor prognosis of patients with invasive IPMN of the pancreas (HR =3.111,95％ confidence interval:1.271-7.614,P＜0.05).(3) The stratified analysis:a median survival time and 1-,3-,5-year survival rates were respectively 56.9 months,97％,57％,49％ in 29 patients with negative lymph nodes and 14.4 months,75％,15％,15％ in 12 patients with positive lymph nodes,with a statistically significant difference (x2 =11.552,P ＜ 0.05).Conclusion The histopathological subtypes and pathological type of canceration have limited prognostic value on invasive IPMN of the pancreas,however,the positive lymph nodes are an independent risk factor affecting the poor prognosis of patients with invasive IPMN of the pancreas.

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma

Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas

Evaluation of intraductal papillary mucinous neoplasms of the pancreas on MDCT and MRI]

Individualized Surgical Treatment and Prognosis of Intraductal Papillary Mucinous Neoplasms of the Pancreas

[Clinical Features and Prognosis of Intraductal Papillary Mucinous Neoplasms of Pancreas: Analysis of 38 Cases].

Systematic Review and Meta-Analysis Comparing the Surgical Outcomes of Invasive Intraductal Papillary Mucinous Neoplasms and Conventional Pancreatic Ductal Adenocarcinoma

Surgical treatment and prognosis of 96 cases of intraductal papillary mucinous neoplasms of the pancreas: A retrospective cohort study

Difference Between Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcinoma

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma

Comparison of patients with invasive intraductal papillary mucinous carcinoma and invasive ductal carcinoma of the pancreas: a pathological type- and stage-matched analysis

Comparison of Invasive Pancreatic Ductal Adenocarcinoma versus Intraductal Papillary Mucinous Neoplasm: A National Cancer Database Analysis

Prognostic Analysis of Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas

Survival Outcomes of Pancreatic Intraepithelial Neoplasm (PanIN) versus Intraductal Papillary Mucinous Neoplasm (IPMN) Associated Pancreatic Adenocarcinoma

Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection

The clinicopathologic features of intraductal papillary mucinous neoplasms of the pancreas

Intraductal papillary mucinous neoplasm of pancreas: Clinicopathological features and long-term survival after surgical resection

Preoperative predictors of malignancy and invasive carcinoma in intraductal papillary mucinous neoplasms

Invasive intraductal oncocytic papillary neoplasms (IOPN) and adenocarcimoma arising from intraductal papillary mucinous neoplasms (A-IPMN) of the pancreas: comparative analysis of clinicopathological features, patterns of recurrence and survival: a multicentre study

An Analysis of Clinico-Pathologic Features of Intraductal Papillary Mucinous Neoplasm of the Pancreas.

Epidemiology and outcome of individuals with intraductal papillary neoplasms of the bile duct

Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucinous Neoplasm versus Primary Pancreatic Ductal Adenocarcinoma: An Analysis from the German Cancer Registry Group of the Society of German Tumor Centers